Mitsubishi UFJ Asset Management’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
Other funds holding NVCR
DTC
Mitsubishi UFJ Asset Management's NVCR Position: Q3 2023 in Review
Mitsubishi UFJ Asset Management sold out of NovoCure (NVCR) in Q3 2023, closing a stake of 32,961 shares — an estimated $1.37M sold.
Mitsubishi UFJ Asset Management first reported a position in NVCR in Q1 2018 and held it in 19 quarters. The position peaked at $4.43M in Q2 2021. 226 funds tracked by Wall St. Rank hold NVCR as of Q3 2023.
- Mitsubishi UFJ Asset Management reported no remaining NovoCure position as of Q3 2023 after selling out during the quarter.
- Mitsubishi UFJ Asset Management sold 32,961 NovoCure shares in Q3 2023, an estimated $1.37M.
- Mitsubishi UFJ Asset Management first reported a position in NovoCure in Q1 2018 and held it in 19 quarters.
- Mitsubishi UFJ Asset Management's NovoCure position peaked at $4.43M in Q2 2021.
- 226 funds tracked by Wall St. Rank held NovoCure as of Q3 2023.
Based on Mitsubishi UFJ Asset Management's 13F filing for Q3 2023, filed 7 Nov 2023.